ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
75 hedge funds and large institutions have $383M invested in Alder Biopharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
12% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 25
Holders
75
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$11.7M | |
| 2 | +$11.5M | |
| 3 | +$6.18M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$2.91M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.57M |
Top Sellers
| 1 | -$20.5M | |
| 2 | -$11.6M | |
| 3 | -$5.82M | |
| 4 |
Jennison Associates
New York
|
-$2.27M |
| 5 |
Millennium Management
New York
|
-$2M |